Production Featured Articles

  1. Is Continuous Manufacturing A Good Fit For Generic Drug Products? 7/25/2019

    Continuous manufacturing (CM), though well recognized by regulators and technology providers as a means to improve product quality, has seen a slow pace of adoption within the generic manufacturing sector. This article discusses the challenges and mitigation strategies for adoption of CM by generic drug product manufacturers.

  2. Where To Next With Continuous Processing? 7/16/2019

    Today multiple suppliers offer commercial process solutions for continuous cell culture, continuous clarification, continuous chromatography, continuous virus inactivation and continuous filtration and their effectiveness is documented in the technical literature. So, what’s next? We have the tools; the technology is proven and early adopters are active.

  3. Bio/Pharma Maintenance 4.0: How To Get Started 7/5/2019

    Part 1 of this two-part series looked at the core aspects of Maintenance 4.0 and outlined a comprehensive maintenance process flow. In this second part, we will discuss how to get started with Maintenance 4.0, along with how to develop benchmark metrics that allow assessment of the gap between the current and desired states.

  4. Managing Risks With Potent Pharmaceutical Products 7/2/2019

    Managing the risks associated with potent compounds requires a knowledgeable team as well as the design and implementation of an effective safety program.

  5. Keeping Pace With Increasing Biopharmaceutical Manufacturing Demand 6/21/2019

    Today’s biologics pipeline is healthy, but forecasts indicate growth so robust the industry risks being ill-equipped to meet demand. Will contract manufacturers to rise to the demand challenge?

  6. Maintenance 4.0: The Next Revolution In Bio/Pharma Manufacturing 6/21/2019

    The next stage in maintenance management, Maintenance 4.0, is to go beyond predictive to the initial stage of an asset — commissioning the assets and deploying the same tools and techniques to set the measures within the design specification from the beginning onward, and using indicative measures to keep the asset in its original design specification.

  7. Optimize Your Lyophilization Process Using Minimal Drug Substance 6/18/2019

    Scale-up and technology transfer of lyophilization processes remain a challenge. Here's how advances in steady-state computer modeling and bench-scale lyophilization practices are driving process optimization with minimal drug substances.

  8. Equipment Change Control For GMP Production Facilities — How To Start 6/5/2019

    While many may conceptually understand change control for equipment and facilities, most lack the knowledge to apply this control to highly sophisticated equipment and the utilities to which they connect.

  9. Is Continuous Manufacturing Right For Your Drug? 5/30/2019

    Adapting any manufacturing process to continuous manufacturing requires in-depth chemical and mechanical engineering understanding as well as the right technologies.

  10. Answering Today’s Pharma Dilemma Of Build Or Buy 5/22/2019

    A new business and operating model may address the build or buy dilemma, offering an innovative and agile way to manage demand uncertainty and reduce the risks associated with early investment decisions.